For the Inventor, By the Inventor

Enter assignee name

Milpitas, CA, United States of America

Genpharm International, Inc.

USPTO Granted Patents = 28

EPO Patents = 1

Forward Citations = 13,172

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Robert M Kay (18 out of 34 patents)

Nils Lonberg (17 out of 66 patents)

Antonius J Berns (4 out of 7 patents)

4. Anton J Berns (4 out of 5 patents)

5. Paulus J Krimpenfort (4 out of 4 patents)

6. Dianne M Fishwild (3 out of 3 patents)

7. Hein Te Riele (2 out of 2 patents)

8. Els Robanus Maandag (2 out of 2 patents)

9. Antonius Jozef Maria Berns (1 out of 1 patent)

10. Paulus Jacobus Angelinus Krimpenfort (1 out of 1 patent)

11. Rein Strijker (1 out of 7 patents)

12. Paul J Krimpenfort (1 out of 7 patents)

13. Frank R Pieper (1 out of 9 patents)

14. Jeffrey M Rosen (1 out of 5 patents)

15. Theodore K Choi (1 out of 1 patent)

28 patents: Sort by Forward Citations

1. 8293480 - Transgenic non-human animals for producing chimeric antibodies (2012-10-23),

2. 8231877 - Heterologous antibodies which bind human CD4 (2012-07-31),

3. 7722873 - Heterologous antibodies which bind human CD4 (2010-05-25),

4. 7084260 - High affinity human antibodies and human antibodies against human antigens (2006-08-01),

5. 7041871 - Transgenic non-human animals capable of producing heterologous antibodies (2006-05-09),

6. 6653113 - High efficiency gene targeting in mouse embryonic stem cells (2003-11-25),

7. 6384298 - Transgenic mice depleted in a mature lymphocytic cell-type (2002-05-07),

8. 6300129 - Transgenic non-human animals for producing heterologous antibodies (2001-10-09),

9. 6255458 - High affinity human antibodies and human antibodies against digoxin (2001-07-03),

10. 6023010 - Transgenic non-human animals depleted in a mature lymphocytic cell-type (2000-02-08),

11. 5877397 - Transgenic non-human animals capable of producing heterologous (1999-03-02),

12. 5874299 - Transgenic non-human animals capable of producing heterologous antibodies (1999-02-23),

13. 5814318 - Transgenic non-human animals for producing heterologous antibodies (1998-09-29),

14. 5789650 - Transgenic non-human animals for producing heterologous antibodies (1998-08-04),

15. 5789215 - Gene targeting in animal cells using isogenic DNA constructs (1998-08-04),

Genpharm International, Inc. is a global pharmaceutical company specializing in the research, development, and production of advanced generic medications. With a strong emphasis on quality and innovation, we are committed to providing safe, effective, and affordable healthcare solutions to patients worldwide. Through strategic partnerships and state-of-the-art manufacturing facilities, we ensure the highest standards of quality and compliance are met at every step of the production process. Our extensive product portfolio covers a wide range of therapeutic areas, including cardiovascular, central nervous system, respiratory, and more. At Genpharm International, we strive to improve global health outcomes by making high-quality medications accessible to all.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

28 Patents

#66 in Milpitas, CA

#2,767 in California

#11,610 in US

#22,565 in the World

Milpitas, CA, United States of America

Genpharm International, Inc.

Forward Citations = 13,172

16 inventors:

Robert M Kay (18 out of 34 patents)

Nils Lonberg (17 out of 66 patents)

Antonius J Berns (4 out of 7 patents)

4. Anton J Berns (4 out of 5 patents)

5. Paulus J Krimpenfort (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…